Molecular diagnostics devices and equipment refer to tools that are used to detect and analyze biological markers in the genome and proteome. These devices help identify diseases, infections and genetic conditions by analyzing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins. They are essential for diagnosing conditions such as cancer, infectious diseases, genetic disorders and other conditions, offering more accurate and rapid results than traditional methods.
The molecular diagnostics devices and equipment market consists of sales, by entities (organizations, sole traders and partnerships), of molecular diagnostics devices and equipment that are used to diagnose diseases and perform screening by detecting specific sequences in DNA, RNA and proteins at a molecular level.
The global molecular diagnostics devices and equipment market was valued at $6,830.97 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 20.00%.
High Prevalence Of Infectious Diseases
The high prevalence of infectious diseases supported the growth of the molecular diagnostics devices and equipment market during the historic period. The increasing prevalence of infectious diseases such as HIV, tuberculosis, influenza and most recently, COVID-19, has significantly heightened the demand for accurate and timely diagnostic solutions. The molecular diagnostics devices and equipment became essential for early detection, monitoring and treatment decisions, leading to higher investments in research and development. For instance, in 2023, according to the World Economic Forum, a Switzerland-based international non-governmental organization, infections such as influenza and respiratory syncytial virus (RSV) have increased since the pandemic. In the USA, an estimated 24 million illnesses, 260,000 hospitalizations and 16,000 deaths from the influenza have occurred as of February 2023. Additionally, in 2022, according to the World Health Organization, 10.6 million people were infected with tuberculosis globally, with 1.3 million deaths attributed to tuberculosis. Therefore, high prevalence of infectious diseases drove the molecular diagnostics devices and equipment market.
Focus On Next-Generation qPCR Systems To Enhance Usability And Custom Test Development
Companies operating in the molecular diagnostics devices and equipment market are developing next-generation quantitative polymerase chain reaction (qPCR) systems to enhance usability and custom test development. These next-generation qPCR systems are designed to enhance usability and support custom test development, addressing the growing clinical needs and public health challenges. For example, in October 2023, F. Hoffmann-La Roche AG, a Switzerland-based healthcare company, introduced its next-generation qPCR system, the LightCycler PRO System, designed to meet the evolving clinical needs in molecular diagnostics and address public health challenges. This advanced system enhances performance and usability, enabling healthcare professionals to seamlessly transition between research and clinical applications. It supports the development of custom tests and includes a comprehensive portfolio of over 200 research assays and more than 60 Conformite Europeenne In-Vitro Diagnostic (CE-IVD) assays.
The global molecular diagnostics devices and equipment market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up to 73.25% of the total market in 2023.
Molecular Diagnostics Devices And Equipment Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global molecular diagnostics devices and equipment market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for molecular diagnostics devices and equipment? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The molecular diagnostics devices and equipment market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider molecular diagnostics devices and equipment market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by technology, by application and by end-user.
- Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the molecular diagnostics devices and equipment market.
- Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
- Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by technology, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
- Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
- Competitive Dashboard- Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations- This section includes recommendations for molecular diagnostics devices and equipment providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
- 1) By Product: Instruments; Reagents And Consumables; Software
- 2) By Technology: DNA (Deoxyribonucleic Acid) Sequencing; Polymerase Chain Reaction; Isothermal Nucleic Acid Amplification Technology; Transcription Mediated Amplification (TMA); In Situ Hybridization; Microarrays; Other Technologies
- 3) By Application: Cancer; Pharmacogenomics; Genetic Testing; Infectious Disease; Prenatal; Other Applications
- 4) By End User: Diagnostic Laboratories; Hospitals; Other End-Users
- Companies Mentioned: F. Hoffmann-La Roche AG; Danaher Corporation; Thermo Fisher Scientific Inc.; Hologic Inc.; QIAGEN N.V.
- Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time-series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; molecular diagnostics devices and equipment indicators comparison.
- Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.